The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.

Meetings  February 2019 Next
  • ACSMEDI-EFMC: Medicinal Chemistry Frontiers 2017

    June 25-28, 2017   Philadelphia (Sheraton Downtown), USA

    ACSMEDI-EFMC Frontiers 2017 Symposium is the sixth in the series initiated in Siena, Italy in 2007 and continued in Barcelona, Spain in 2009, Stockholm, Sweden in 2011, San Francisco, CA in 2013 and Antwerp, Belgium in 2015. The meeting is co-organized by the European Federation of Medicinal Chemistry and the American Chemical Society Division of Medicinal Chemistry. It is intended to bring scientists working in the medicinal chemistry field together in order to share new and exciting results and we encourage attendees to bring poster presentations. Philadelphia provides a picturesque backdrop for this exciting conference, and we know you will have a scientifically rewarding and enjoyable stay.

    Frontiers 2017 will take place in the Sheraton Philadelphia Downtown Hotel, located at 201 N. 17th Street St., located in the heart of Philadelphia. The Sheraton Philadelphia Downtown is in close proximity to historic Philadelphia, the Liberty Bell, the Reading Terminal Market and the Franklin Institute, making it an ideal location to enjoy the city, and to experience the latest research in medicinal chemistry.


    • Douglas Beshore, Merck
    • David Chenoweth,University of Pennsylvania
    • Emily Cherney, Bristol-Myers Squibb
    • Craig Crews, Yale University
    • Andrew Degnan, Bristol-Myers Squibb
    • Robert Glen , University of Cambridge
    • Phillip Harris, GlaxoSmithKline USA
    • Thomas Hermann, University of California at San Diego
    • Michael Jung, University of California at Los Angeles
    • György Miklós Keseru, Hungarian Academy of Sciences
    • Andreas Linkermann, Universitätlinikum Carl Gustav Carus
    • Jing Liu, Mount Sinai Research
    • Christa E. Müller, University of Bonn
    • Snahel Patel, Genentech
    • Philip Pitis, Trevana Pharmaceuticals
    • Barry Potter, Oxford University
    • Hasane Ratni, Roche
    • Dustin Siegel, Gilead
    • Michael Sofia, Arbutus
    • Dai-Shi Su, GlaxoSmithKline USA
    • Peter Vandenabeele, Ghent University
    • Koen Vandyck, Johnson and Johnson
    • Eddy Yue, Incyte



  • Frontiers in Medicinal Chemistry 2015

    September 14-16, 2015   Antwerp, belgium

    The Frontiers in Medicinal Chemistry symposium is co-organised on a biennial basis, as a collaboration between the ACS (American Chemical Society) and the EFMC (European Federation for Medicinal Chemistry).

    Frontiers in Medicinal Chemistry 2015 will be jointly organised by EFMC, ACS and the local Dutch and Belgian organisers: the Medicinal and Bioorganic Chemistry Division of the Royal Flemish Chemical Society (KVCV, Belgium), the Société Royale de Chimie (SRC, Belgium), and the Section Medicinal Chemistry of the Royal Netherlands Chemical Society (KNCV, The Netherlands).

    The 2015 edition of the symposium took place in Antwerp, Belgium, from September 14-16, 2015.

    Session topic areas included:

    • Molecular Chaperones and their Therapeutic Potential
    • Unexplored Chemical Space: Experiences from the European Lead Factory and the NIH Molecular Libraries Programme
    • Emerging Advances in GPCR Research
    • Emerging Topics
    • Non-Small Molecules
    • Novel Strategies for Anti-Thrombotic Therapy
    • Kinetics and Thermodynamics of Ligand Binding
    • Rational Design of Non-Oral Drugs
    • Academic Drug Discovery

  • Frontiers in Medicinal Chemistry 2013

    June 23-26, 2013   San Francisco, US

    Co-organised by the European Federation for Medicinal Chemistry and the Division of Medicinal Chemistry of ACS.

    Frontiers 2013 took place in the historic Fairmont Hotel, located at 950 Mason St. on Nob Hill, in the heart of San Francisco. Central to the Financial District, Union Square, the Embarcadero and Fisherman's Wharf, the Fairmont Hotel is located at the only spot in San Francisco where each of the City's cable car lines meet.
    The scientific program for Frontiers 2013 featured a plenary session, followed by sessions covering the latest advances in medicinal chemistry.

    Session topic areas included:
    • Antiviral Drug Design
    • Advances in the Treatment of Inflammation
    • Imaging, Biomarkers & Translational Research
    • Oncology
    • Antibody/Drug Conjugates
    • Molecular Modeling and Structure-Based Design
    • Emerging Topics

  • Frontiers in Medicinal Chemistry 2011:
    Emerging Targets, Novel Candidates and Innovative Strategies

    June 19-21, 2011   Stockholm, Sweden

    The Meeting has been co-organized by the European Federation for Medicinal Chemistry, the Division of Medicinal Chemistry of ACS and the Swedish Academy of Pharmaceutical Sciences. It brought together speakers from Scandinavia/Europe and USA that shared exciting new results and first time disclosures in several areas of drug discovery.

    Topics included:
    • ADME Profiling
    • Cancer and Epigenetics
    • Case Studies and Emerging Targets
    • Chemical Neuroscience
    • GPCR´s
    • Protein-Protein Interactions
    • Structure Based Ligand Design


  • Frontiers in Medicinal Chemistry 2009:
    Emerging Targets, Novel Candidates and Innovative Strategies

    October 4-6, 2009   Barcelona, Spain

    Under the theme of “Emerging Targets, Novel Candidates and Innovative Strategies”, this three-day international meeting will bring together medicinal chemists and related scientists in order to share exciting new results and first-time disclosures in various areas of drug discovery and development, including cancer, infectious diseases, CNS, inflammation, pain and metabolic disease. Twenty-three internationally recognized plenary speakers will present lectures with a focus on emerging targets, novel drug candidates and new strategies and technologies. Furthermore, poster sessions will help to strengthen ties between scientists in an environment that will foster interaction and discussion.

    Contact person: M.L. López-Rodriguez
    Tel: +34-91-3944-239
    Fax: +34-91-3944-103

  • Frontiers in CNS and Oncology Medicinal Chemistry

    October 7-9, 2007   Siena, Italy

    This 3 day international brought together medicinal chemists from the US and Italy to share exciting new results in central nervous system and oncology medicinal chemistry presented by leading academic and industrial researchers. These therapeutic areas are a special strength in Italy, and complements interest in US-based drug discovery research. Substantial progress is being made in the medicinal chemistry of these fields, and will be reflected in the scientific program. There were ample interactive opportunities in scenic Siena for attendees to explore collaborative research possibilities.

28 29 30 31 01 02 03
04 05 06 07 08 09 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 01 02 03
All events   |  Future events

Job portal

Life Science Business Development Manager Europe Asia, Hybrigenics Services SAS: Business Development Europe Asia, Paris or European city, France
read more

Job portal page

Follow us on Facebook

Follow us on Twitter

Follow us on LinkedIn

Follow us on Instagram

ChemBridgeBoehringer IngelheimNovartisProf Dr W. Th. Nauta FoundationPfizerServierRocheSanofi
Prous Institute for Biomedical ResearchUCBJanssen R&DBayerMerckAstra ZenecaIdorsia